Login
$OCUL
$6.72 +$0.25 (3.86%) Close

Company Executives

$OCUL Management Team

Dr. Jeffrey Heier

Chief Scientific Officer

Age 64
Compensation $6.599M USD
Sex Male

Dr. Sanjay Nayak

Chief Strategy Officer

Age 55
Compensation -
Sex Male

Dr. Pravin Dugel

Executive Chairman of the Board

President

Chief Executive Officer

Age 61
Compensation $18.57M USD
Sex Male

Dr. Peter Kaiser

Chief Development Officer

Age 58
Compensation $6.629M USD
Sex Male

Dr. Nadia Waheed

Chief Medical Officer

Age 48
Compensation -
Sex Female

Mr. Todd Anderman

Chief Legal Officer and Secretary

Age 43
Compensation -
Sex Male

Mr. Jason Robins

Interim Chief Financial Officer

Age 49
Compensation -
Sex Male
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
Not stated
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards Pay Source
Pravin U. Dugel, M.D.
Not stated Not stated Not stated None stated None stated Not stated
Merilee Raines
Not stated Not stated Not stated
Audit Committee · Chair
None stated Not stated
Adrienne L. Graves, Ph.D.
Not stated Not stated Not stated
Nominating and Corporate Governance Committee
None stated Not stated
Charles Warden
Not stated Not stated Not stated
Audit Committee Compensation Committee · Chair
None stated Not stated
Seung Suh Hong, Ph.D.
Not stated Not stated Not stated
Nominating and Corporate Governance Committee
None stated Not stated
Richard L. Lindstrom, M.D.
Not stated Not stated Not stated
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated Not stated
Leslie J. Williams
Not stated Not stated Not stated
Audit Committee Compensation Committee
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support